Adlon Therapeutics L.P. is a biopharmaceutical company dedicated to developing and providing treatment options for ADHD and related disorders. Adlon's initial focus is on adults and adolescents who suffer from symptoms of Attention Deficit/Hyperactivity Disorder (ADHD). Adlon is a subsidiary of Purdue Pharma L.P.
ADDitude’s Editorial and Medical Review Process
ADDitude is dedicated to publishing quality content that adheres to the highest scientific and editorial standards. Created by qualified writers and medical professionals, our content is fact-checked and reviewed by members of the ADDitude Medical Advisory Panel, including leading clinical practitioners and researchers within the field of ADHD. The ADDitude team adheres to strict editorial standards and journalistic principles. Health information and guidance is thoroughly researched, and sources are vetted to ensure recency, authority, and credibility.
ADDitude editors regularly revisit and update existing content for accuracy and reliability, often in coordination with ADDitude’s Medical Advisory Panel and according to the ADDitude Editorial Process.